Correlation Between GeneFerm Biotechnology and DV Biomed

Can any of the company-specific risk be diversified away by investing in both GeneFerm Biotechnology and DV Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneFerm Biotechnology and DV Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneFerm Biotechnology Co and DV Biomed Co, you can compare the effects of market volatilities on GeneFerm Biotechnology and DV Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneFerm Biotechnology with a short position of DV Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneFerm Biotechnology and DV Biomed.

Diversification Opportunities for GeneFerm Biotechnology and DV Biomed

0.21

Correlation Coefficient

GeneFerm Biotechnology  DV Biomed

Modest diversification

The 3 months correlation between GeneFerm and 6539 is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding GeneFerm Biotechnology Co and DV Biomed Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DV Biomed and GeneFerm Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneFerm Biotechnology Co are associated (or correlated) with DV Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DV Biomed has no effect on the direction of GeneFerm Biotechnology i.e., GeneFerm Biotechnology and DV Biomed go up and down completely randomly.

Pair Corralation between GeneFerm Biotechnology and DV Biomed

Assuming the 90 days trading horizon GeneFerm Biotechnology Co is expected to generate 0.28 times more return on investment than DV Biomed. However, GeneFerm Biotechnology Co is 3.55 times less risky than DV Biomed. It trades about 0.19 of its potential returns per unit of risk. DV Biomed Co is currently generating about -0.1 per unit of risk. If you would invest  5,480  in GeneFerm Biotechnology Co on April 7, 2024 and sell it today you would earn a total of  1,030  from holding GeneFerm Biotechnology Co or generate 18.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

GeneFerm Biotechnology Co  vs.  DV Biomed Co

GeneFerm Biotechnology

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, GeneFerm Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

DV Biomed

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DV Biomed Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in August 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with GeneFerm Biotechnology and DV Biomed

The main advantage of trading using opposite GeneFerm Biotechnology and DV Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneFerm Biotechnology position performs unexpectedly, DV Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DV Biomed will offset losses from the drop in DV Biomed's long position.

The idea behind GeneFerm Biotechnology Co and DV Biomed Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.